These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 5471995)

  • 1. [Serum gamma-glutamyl transpeptidase: a sensitive indicator in hepatobiliary disorders].
    Kammeraat C
    Ned Tijdschr Geneeskd; 1970 Oct; 114(44):1814-6. PubMed ID: 5471995
    [No Abstract]   [Full Text] [Related]  

  • 2. [Gamma glutamyl transpeptidase activity in the serum in hepatobiliary diseases].
    Szasz G; Rosenthal P; Fritzsche W
    Dtsch Med Wochenschr; 1969 Sep; 94(38):1911-7. PubMed ID: 5806488
    [No Abstract]   [Full Text] [Related]  

  • 3. [Gamma-glutamyl-transpeptidase, leucine aminopeptidase and alkaline phosphatase. Comparison of 3724 serums].
    Szasz G; Rosenthal P; Fritzsche W
    Schweiz Med Wochenschr; 1969 Apr; 99(16):606-8. PubMed ID: 5768022
    [No Abstract]   [Full Text] [Related]  

  • 4. [Gamma-glutamyl transpeptidase values in liver and bile duct diseases. Clinical observations and experimental trials].
    Bertrand L; Arnefaux J
    Ann Med Interne (Paris); 1973 Mar; 124(3):173-80. PubMed ID: 4146099
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative studies on the behavior of alkaline phosphatase, leucylaminopeptidase and gamma-glutamyltranspeptidase in the diseases of the bile ducts and liver].
    Cichecka K; Drozdz H; Jedrychowski A
    Pol Tyg Lek; 1970 Jul; 25(28):1037-9. PubMed ID: 5456851
    [No Abstract]   [Full Text] [Related]  

  • 6. [Evaluation of determination of -glutamyl transpeptidase ( -GT) in hepatobiliary diseases].
    Saragoni A; Gardini G; Lazzari L; Savoia M
    Quad Sclavo Diagn; 1972 Mar; 8(1):368-73. PubMed ID: 4145982
    [No Abstract]   [Full Text] [Related]  

  • 7. [Gamma-glutamyl transpeptidase activity in pancreatic and hepato-biliary pathology. Comparison with alkaline phosphatases and 5-nucleotidase].
    Touboul JP; Hecht Y; Feneant M; Van Batten R
    Med Chir Dig; 1975; 4(4):227-32. PubMed ID: 1606
    [No Abstract]   [Full Text] [Related]  

  • 8. [Behavior of gamma glutamyl transpeptidase in hepatobiliary diseases].
    Kresbach E; Thurnher H
    Wien Med Wochenschr; 1973 Apr; 123(16):253-8. PubMed ID: 4144931
    [No Abstract]   [Full Text] [Related]  

  • 9. [Behavior of the principal serum enzyme activities in the course of hepatobiliary diseases].
    Papini E; Pagano A; Panunzi C; Ponzo M; Rovagna MC; Picardi R
    Recenti Prog Med; 1978 Sep; 65(3):277-85. PubMed ID: 30121
    [No Abstract]   [Full Text] [Related]  

  • 10. Determination of gamma glutamyl transpeptidase activity in human serum. Its use in oncology.
    Delarue JC; Sancho H; Rouesse J; Bohuon C
    Biomedicine; 1973 Mar; 18(2):152-8. PubMed ID: 4147288
    [No Abstract]   [Full Text] [Related]  

  • 11. [Serum 5'nucleotidase activity in hepatobiliary diseases].
    Cortés Rius M; Ferragút Canals A; Simón Lamuela MA; Gosalvez AM; Esque Bernadas C; Concustell Bas E
    Rev Clin Esp; 1975 Jul; 138(2):137-41. PubMed ID: 1178958
    [No Abstract]   [Full Text] [Related]  

  • 12. [Serum glutamyl transpeptidase activity in liver and biliary tract diseases].
    Terletskaia LM
    Vrach Delo; 1981 Oct; (10):69-72. PubMed ID: 6117984
    [No Abstract]   [Full Text] [Related]  

  • 13. Change of serum -glutamyl transpeptidase level and isoenzyme pattern in hepatobiliary pancreatic disease.
    Miyazaki S; Okumura M
    Clin Chim Acta; 1972 Aug; 40(1):193-7. PubMed ID: 5056628
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum -glytamyl transpeptidase activity in liver disease.
    Whitfield JB; Pounder RE; Neale G; Moss DW
    Gut; 1972 Sep; 13(9):702-8. PubMed ID: 4404786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The glutamic pyruvic transaminase-alkaline phosphatase quotient in hepatic pathology].
    Ledro Molina D
    Rev Esp Enferm Apar Dig; 1974 Mar; 43(2):183-92. PubMed ID: 4840487
    [No Abstract]   [Full Text] [Related]  

  • 16. [Rational clinico-chemical diagnosis of hepatobiliary diseases].
    Blum HE; von Weizsäcker F
    Internist (Berl); 1991 May; 32(5):239-43. PubMed ID: 1678385
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum gamma-glutamyl transpeptidase acitivity. I. Clinical study.
    Wu JS
    Taiwan Yi Xue Hui Za Zhi; 1972 Jan; 71(1):26-41. PubMed ID: 4504408
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum gamma-glutamyl transpeptidase activity as an indicator of disease of liver, pancreas, or bone.
    Lum G; Gambino SR
    Clin Chem; 1972 Apr; 18(4):358-62. PubMed ID: 5012259
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparative evaluation of the diagnostic importance of determining 5-nucleotidase and alkaline phosphatase in the blood serum in liver and biliary tract diseases].
    Terletskaia LM
    Vestn Khir Im I I Grek; 1981 Oct; 127(10):47-51. PubMed ID: 6274079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative study of the behavior of gamma-glutamyl transpeptidase in hepatobiliary pathology].
    Caballería Rovira E; Sanchís Closa A; Arago López JV; Brunetti Novella JM
    Rev Esp Enferm Apar Dig; 1986 Jun; 69(6):501-7. PubMed ID: 2874595
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.